Immunological and endocrinological characteristics of tuberculosis that provide opportunities for immunotherapeutic intervention

Novartis Foundation Symposium

Volumn , Issue 217, 1998, Pages 73-98

  Rook, Graham A W ^a   Hernandez Pando, Rogelio ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GLUCOCORTICOID; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL TRIAL; ENDOCRINE GLAND; IMMUNOLOGY; IMMUNOTHERAPY; LUNG TUBERCULOSIS; METABOLISM; REVIEW; TH1 CELL; TH2 CELL;

BCG VACCINE; CLINICAL TRIALS; ENDOCRINE GLANDS; GLUCOCORTICOIDS; IMMUNOTHERAPY; TH1 CELLS; TH2 CELLS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032248829     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (7)

1. Abou-Zeid C, Gares M-P, Inwald J et al 1997 Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun 65:1856-1862
2. Anderson MC 1891 On Koch's treatment. Lancet i:651-652
3. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL 1993 Cytokine production at the site of disease in tuberculosis. Infect Immun 61:3482-3489
4. Cohen IR 1996 Heat shock protein 60 and the regulation of autoimmunity. In: van Eden W, Young DB (eds) Stress proteins in medicine. Marcel Dekker, New York, p 93-102
5. Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA 1997 Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania, 2. Chronic or relapsed disease. Respir Med 91:21-29
6. Donald PR, Beyers N, Rook GAW 1996 Adolescent tuberculosis. S Afr Med J 86:231-233
7. Escher G, Frey FJ, Frey BM 1994 11-β-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney. Endocrinology 135:101-106